Andrew Scott wins grant for national brain cancer study

Federal Health Minister Greg Hunt announced Professor Scott, from Austin Health, the Olivia Newton-John Cancer Research Institute and La Trobe's School of Cancer Medicine will receive $1,520,000 over five years from the Medical Research Future Fund (MRFF) to run a clinical trial involving patients with high-grade glioma or glioblastoma (GBM).

The MRFF supports Australia's brightest medical researchers in their fight against rare cancers and rare diseases.

Professor Scott, Director of the Department of Molecular Imaging and Therapy at Austin Health, said his multi-centre study would bring together 19 investigators from major hospitals and universities around Australia and will investigate the role of FET-PET imaging technology in the treatment of GBM patients.

"Currently only 25 per cent of patients with GBM are still alive two years after diagnosis and just 10 percent live for 5 years, despite receiving treatment," Dr Scott said.

"New imaging techniques that incorporate prognostic information are required to improve patient outcomes by individualising patient care.

"Our trial will investigate how we can use the FET-PET technology to provide more accurate treatment and improve survival rates."

Austin Health will be one of the trial sites for the study.

The Health Minister has also announced that Professor Scott will be a member of the Strategic Advisory Group that will support the $100 million Australian Brain Cancer Mission.

The Mission is a partnership between the Federal Government, philanthropists, medical experts, patient and their families. Its aim is to double survival rates for people living with brain cancer over the next 10 years.